// App-Quantinova.ai

AB0573 : TOCILIZUMAB USE IN A DIVERSE PATIENT POPULATION: SINGLE-CENTRE TERTIARY EXPERIENCE

Researchers

Presenter

  • S.C. Horton

Principal Investigators

  • S. Das

  • D. Bryer

  • P. Emery

  • M.H. Buch

Medical Centers

  • Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Rheumatoid arthritis

  • Adult onset Still's disease

  • Hypogammaglobulinaemia

  • Spondyloarthritis

  • Cardiorenal syndrome

  • Infectious arthritis

  • Neutropenia

  • Inflammatory Arthritis

  • Sepsis

Biomarkers

  • C reactive protein

Drug/Treatment

  • Hydroxychloroquine

  • Methotrexate

  • Tocilizumab

  • HWA-486

  • Abatacept

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved